Targeting CD47 in Sézary syndrome with SIRPαFc

Sézary syndrome (SS), the leukemic variant of cutaneous T-cell lymphoma, has limited treatment options and rare occurrences of long-term remission, thus warranting research into new treatment approaches. CD47 has emerged as a promising target for multiple tumor types, but its role in SS remains unkn...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Adv
Päätekijät: Johnson, Lisa D. S., Banerjee, Swati, Kruglov, Oleg, Viller, Natasja Nielsen, Horwitz, Steven M., Lesokhin, Alexander, Zain, Jasmine, Querfeld, Christiane, Chen, Robert, Okada, Craig, Sawas, Ahmed, O’Connor, Owen A., Sievers, Eric L., Shou, Yaping, Uger, Robert A., Wong, Mark, Akilov, Oleg E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2019
Aiheet:
Lymphoid Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457236/
https://ncbi.nlm.nih.gov/pubmed/30962222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018030577
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia